Physician profile
Michael Patrick Cullen
NPI 1851329114
$8,220.70
in general payments reported to CMS, 2019-2025
12 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $511 · 2021: $5,088 · 2022: $242 · 2023: $771 · 2024: $365 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,574 · Travel and Lodging: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.21 |
| Travel and Lodging | $220.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,226.43 | 2021-2023 | |
| Stryker Corporation | $2,224.77 | 2019-2025 | Ortholoc 2 Lapifuse, Viaflow, Augment Injectable |
| Conetic Solutions, INC. | $2,191.01 | 2019-2024 | |
| Wright Medical Technology, INC. | $248.37 | 2019-2020 | |
| Avinger INC. | $117.71 | 2019 | |
| Depuy Synthes Sales INC. | $70.02 | 2025 | Motoband, Na |
| Polynovo North America LLC | $46.08 | 2025 | Novosorb Btm |
| Rsw Medical Company, INC. | $32.39 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.95 | 2023 | Jublia |
| Ossio INC | $16.48 | 2023 | |
| Paratek Pharmaceuticals, INC. | $15.72 | 2023 | Nuzyra |
| Nevro Corp. | $13.77 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.